Peroxynitrite Inactivates Tissue Plasminogen Activator

Vance G Nielsen, John P. Crow, Fen Zhou, Dale A. Parks

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Tissue plasminogen activator (tPA) has a prominent role in physiological fibrinolysis in vivo. Thrombosis has been associated with clinical scenarios (e.g., atherosclerotic disease) known to involve local decreases in tPA activity with concomitant formation of reactive nitrogen species such as peroxynitrite (OONO-), a molecule formed from nitric oxide and superoxide. We hypothesized that exposure of tPA to OONO- would result in a decrease in tPA activity. OONO- was generated with 3-morpholinosydnonimine (SIN-1), a molecule that produces both nitric oxide and superoxide. Recombinant tPA was incubated at 37°C for 60 min with 0 μM SIN-1; 100 μM SIN-1; 100 μMSIN-1 and 4000 U/mL recombinant human superoxide dismutase; or 4000 U/mL recombinant human superoxide dismutase (n = 8 separate reactions per condition). Changes in tPA activity were assessed by addition of tPA samples to tissue factor-exposed human plasma and measuring clot fibrinolysis with a thrombelastograph®. Exposure to SIN-1 resulted in a decrease in tPA-mediated fibrinolysis (<1% activity of tPA not exposed to SIN-1) that was significantly (P < 0.001) different from the other three conditions. There were no significant differences between the other conditions. We conclude that tPA is inhibited by OONO-, and that OONO - may have a role in clinical thrombotic scenarios.

Original languageEnglish (US)
Pages (from-to)1312-1317
Number of pages6
JournalAnesthesia and Analgesia
Volume98
Issue number5
StatePublished - May 2004
Externally publishedYes

Fingerprint

Peroxynitrous Acid
Tissue Plasminogen Activator
Fibrinolysis
Superoxides
Superoxide Dismutase
Nitric Oxide
Reactive Nitrogen Species
Thromboplastin
Thrombosis

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Nielsen, V. G., Crow, J. P., Zhou, F., & Parks, D. A. (2004). Peroxynitrite Inactivates Tissue Plasminogen Activator. Anesthesia and Analgesia, 98(5), 1312-1317.

Peroxynitrite Inactivates Tissue Plasminogen Activator. / Nielsen, Vance G; Crow, John P.; Zhou, Fen; Parks, Dale A.

In: Anesthesia and Analgesia, Vol. 98, No. 5, 05.2004, p. 1312-1317.

Research output: Contribution to journalArticle

Nielsen, VG, Crow, JP, Zhou, F & Parks, DA 2004, 'Peroxynitrite Inactivates Tissue Plasminogen Activator', Anesthesia and Analgesia, vol. 98, no. 5, pp. 1312-1317.
Nielsen, Vance G ; Crow, John P. ; Zhou, Fen ; Parks, Dale A. / Peroxynitrite Inactivates Tissue Plasminogen Activator. In: Anesthesia and Analgesia. 2004 ; Vol. 98, No. 5. pp. 1312-1317.
@article{c878e41479534f07bd5609089fc73ee1,
title = "Peroxynitrite Inactivates Tissue Plasminogen Activator",
abstract = "Tissue plasminogen activator (tPA) has a prominent role in physiological fibrinolysis in vivo. Thrombosis has been associated with clinical scenarios (e.g., atherosclerotic disease) known to involve local decreases in tPA activity with concomitant formation of reactive nitrogen species such as peroxynitrite (OONO-), a molecule formed from nitric oxide and superoxide. We hypothesized that exposure of tPA to OONO- would result in a decrease in tPA activity. OONO- was generated with 3-morpholinosydnonimine (SIN-1), a molecule that produces both nitric oxide and superoxide. Recombinant tPA was incubated at 37°C for 60 min with 0 μM SIN-1; 100 μM SIN-1; 100 μMSIN-1 and 4000 U/mL recombinant human superoxide dismutase; or 4000 U/mL recombinant human superoxide dismutase (n = 8 separate reactions per condition). Changes in tPA activity were assessed by addition of tPA samples to tissue factor-exposed human plasma and measuring clot fibrinolysis with a thrombelastograph{\circledR}. Exposure to SIN-1 resulted in a decrease in tPA-mediated fibrinolysis (<1{\%} activity of tPA not exposed to SIN-1) that was significantly (P < 0.001) different from the other three conditions. There were no significant differences between the other conditions. We conclude that tPA is inhibited by OONO-, and that OONO - may have a role in clinical thrombotic scenarios.",
author = "Nielsen, {Vance G} and Crow, {John P.} and Fen Zhou and Parks, {Dale A.}",
year = "2004",
month = "5",
language = "English (US)",
volume = "98",
pages = "1312--1317",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Peroxynitrite Inactivates Tissue Plasminogen Activator

AU - Nielsen, Vance G

AU - Crow, John P.

AU - Zhou, Fen

AU - Parks, Dale A.

PY - 2004/5

Y1 - 2004/5

N2 - Tissue plasminogen activator (tPA) has a prominent role in physiological fibrinolysis in vivo. Thrombosis has been associated with clinical scenarios (e.g., atherosclerotic disease) known to involve local decreases in tPA activity with concomitant formation of reactive nitrogen species such as peroxynitrite (OONO-), a molecule formed from nitric oxide and superoxide. We hypothesized that exposure of tPA to OONO- would result in a decrease in tPA activity. OONO- was generated with 3-morpholinosydnonimine (SIN-1), a molecule that produces both nitric oxide and superoxide. Recombinant tPA was incubated at 37°C for 60 min with 0 μM SIN-1; 100 μM SIN-1; 100 μMSIN-1 and 4000 U/mL recombinant human superoxide dismutase; or 4000 U/mL recombinant human superoxide dismutase (n = 8 separate reactions per condition). Changes in tPA activity were assessed by addition of tPA samples to tissue factor-exposed human plasma and measuring clot fibrinolysis with a thrombelastograph®. Exposure to SIN-1 resulted in a decrease in tPA-mediated fibrinolysis (<1% activity of tPA not exposed to SIN-1) that was significantly (P < 0.001) different from the other three conditions. There were no significant differences between the other conditions. We conclude that tPA is inhibited by OONO-, and that OONO - may have a role in clinical thrombotic scenarios.

AB - Tissue plasminogen activator (tPA) has a prominent role in physiological fibrinolysis in vivo. Thrombosis has been associated with clinical scenarios (e.g., atherosclerotic disease) known to involve local decreases in tPA activity with concomitant formation of reactive nitrogen species such as peroxynitrite (OONO-), a molecule formed from nitric oxide and superoxide. We hypothesized that exposure of tPA to OONO- would result in a decrease in tPA activity. OONO- was generated with 3-morpholinosydnonimine (SIN-1), a molecule that produces both nitric oxide and superoxide. Recombinant tPA was incubated at 37°C for 60 min with 0 μM SIN-1; 100 μM SIN-1; 100 μMSIN-1 and 4000 U/mL recombinant human superoxide dismutase; or 4000 U/mL recombinant human superoxide dismutase (n = 8 separate reactions per condition). Changes in tPA activity were assessed by addition of tPA samples to tissue factor-exposed human plasma and measuring clot fibrinolysis with a thrombelastograph®. Exposure to SIN-1 resulted in a decrease in tPA-mediated fibrinolysis (<1% activity of tPA not exposed to SIN-1) that was significantly (P < 0.001) different from the other three conditions. There were no significant differences between the other conditions. We conclude that tPA is inhibited by OONO-, and that OONO - may have a role in clinical thrombotic scenarios.

UR - http://www.scopus.com/inward/record.url?scp=1942532996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942532996&partnerID=8YFLogxK

M3 - Article

C2 - 15105207

AN - SCOPUS:1942532996

VL - 98

SP - 1312

EP - 1317

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 5

ER -